美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
50742-332-30	50742-332	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.75 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-332-30)
50742-336-30	50742-336	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	3.75 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-336-30)
50742-331-30	50742-331	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.375 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-331-30)
50742-335-30	50742-335	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	3 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-335-30)
50742-333-30	50742-333	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	1.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-333-30)
50742-337-30	50742-337	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	4.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-337-30)
50742-334-30	50742-334	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride	Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310	N/A	ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	2.25 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-334-30)